Site search

We support research across the entire spectrum of medical sciences,
in universities and hospitals, in our own units, centres and institutes in the UK,
and in our units in Africa.


£230 million for technologies to revolutionise research into disease

23 October 2014

The Chancellor of the Exchequer, George Osborne, has today announced that a partnership led by the MRC will invest over £230 million in a range of revolutionary technologies aimed at identifying the causes of diseases such as cancer and dementia.

New cancer drug to begin trials in multiple myeloma patients

13 October 2014

Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year. 

Ambitious new studies will give new insights into Parkinson’s, addiction and the immune system

7 October 2014

Three ambitious new research programmes, which aim to deliver a step-change in our understanding of disease by using human volunteers in experimental studies, have been funded as part of a £60m investment from the Medical Research Council (MRC).

FUNDING: Science areas

Researchers can apply for MRC grant funding at any time.


From the archive: First randomised controlled trial to show spinal cord regeneration in dogs

A technique tested on dogs by MRC researchers in 2012 has helped a paralysed man walk again. The method was first developed in rats by UCL’s Professor Geoffrey Raisman when he worked at the MRC National Institute for Medical Research. Find out more in tonight’s Panorama (21 October).

Sign up

email iconKeep up to date with our latest news

Follow MRC on twitter

MRC insight: blog